Hospitals Partner to Implement First of Its Kind Augmented Reality Surgical Technology

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

George Washington University Hospital, in partnership with Novarad, today announced the country’s first implementation of an augmented reality (AR) medical solution in a surgical setting. Building upon decades of Novarad’s experience in image processing, the OpenSight® Augmented Reality System, powered by Microsoft HoloLens, renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body. The partnership ushers in a new world of pre-operative planning, overcoming critical pre-surgical and surgical obstacles to minimize patient morbidity and mortality.

While some earlier technology was limited in both scope and efficacy, OpenSight, co-created by Dr. Wendell Gibby, Novarad CEO and Dr. Steve Cvetko of OpenSight, was designed to visualize 3D imaging holograms of the patient, on the patient, for pre-operative localization and planning of surgical options. The 3D holograms are created by a refractory system in the device using a combination of the Microsoft HoloLens hardware and OpenSight technology.

“OpenSight allows the surgeon to overlay the medical image onto the patient’s body, so not only do I see the patient laying on top of the table, but I can see the CT hologram,” said Dr. Babak Sarani, professor of surgery and emergency medicine and director of the center for trauma and critical care at George Washington University, “Us having this technology meets the endpoint of our mission as an academic hospital.”

The infrared camera within the headset has ranging and localizing technology, which maps the surrounding environment – including the patient. It determines where objects are and creates mesh surface maps to determine 3D positioning. Placing visual tracking tags on the patient follows movement and allows for even higher accuracy. Image capabilities include virtual incisions to guide the surgeon, shunts, and needle placement; finding the optimal entrance and trajectory for pedicle screws, ACL tunnels and other instrumentation; finding and resecting masses; interventional biopsies, and more.

“A revolution in surgery is beginning and George Washington University is leading the charge,” said Dr. Gibby. “Using the OpenSight augmented reality device from Novarad, doctors can literally see the patient and see into them at the same time. High resolution advanced holographic imaging is merged in 3D onto the patient with optical precision. This transformative technology promises to improve outcomes in a world of more precise medicine.”

The technology available through this partnership will make it possible to highlight relevant anatomical and critical structures to avoid and more accurately plan a surgical approach. Multiple headsets can be shared among users improving the training of less experienced residents. A teaching version of the software is also available that allows medical students to perform virtual dissections on cadavers.

“Novarad’s unique OpenSight system uses the Microsoft HoloLens headset and augments real-world health care environments with virtual 3D patient images, and we are very pleased that they have achieved FDA medical clearance for pre-surgical use of their OpenSight solutions for HoloLens,” said Matt Fleckenstein, Senior Director of Marketing for Microsoft HoloLens at Microsoft Corp. “It’s exciting to see George Washington University Hospital become the first medical team to adopt this new system – empowering its doctors with the technology to improve surgical outcomes.”



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.